Concepedia

Bolin Geng

BG

Statistics

Publications

13

Citations

640

H-Index

13

Active since

1994

Affiliations

AstraZeneca (United States)(Current)

Southern Methodist University

AstraZeneca (United Kingdom)

AstraZeneca (Sweden)

Bolin Geng is an author at AstraZeneca (United States) specializing in medicine, microbiology, and drug resistance.

Top concepts

MedicineMicrobiologyPharmacologyDrug ResistanceAntimicrobial ResistanceDrug DiscoveryNatural SciencesBiochemistryChemical BiologyMedicinal Chemistry

Publications per year

1994–2014

13

Publications

13

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2011 · 101 citations · Full text

Reduced Herg Activity, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +21

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced p<i>K</i><sub>a</sub>: Antibacterial Agents with an Improved Safety Profile

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2012 · 88 citations · Full text

Synthesis and Reactivity of Silylboranes

John D. Buynak, Bolin Geng · Organometallics · 1995 · 73 citations

Engineering, Media Standards, Databases +16

Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase

Losee L. Ling, Jun Xian, Syed Muhammad Adnan Ali et al. · Antimicrobial Agents and Chemotherapy · 2004 · 66 citations · Full text

Antimicrobial Drug Discovery, Biosynthesis, Biochemistry +14

7-Alkylidenecephalosporin Esters as Inhibitors of Human Leukocyte Elastase

John D. Buynak, A. Srinivasa Rao, George P. Ford et al. · Journal of Medicinal Chemistry · 1997 · 63 citations · Full text

1–5 of 13